020P Nottingham, UK
7th Focused Meeting on Cell Signalling

 

 

Effect of intracellular loop 1 pepducins on ligand-receptor binding kinetics at the CXCR4 receptor

B. Caspar1,2, L. A. Stoddart1,2, J. Goulding1,2, S. J. Briddon1,2, S. J. Hill1,2. 1Division of Pharmacology, Physiology and Neuroscience, University of Nottingham, Nottingham, United Kingdom, 2Centre of Membrane Proteins and Receptors (COMPARE), Nottingham, United Kingdom.

Introduction: Pepducins are a class of lipidopeptide ligands derived from the intracellular loops of a GPCR and have been reported to act as allosteric modulators, although their exact mechanism remains unclear.1 Pepducins for the chemokine receptor, CXCR4, have been described to act as positive or negative allosteric modulators and can exhibit agonist activity in the absence of the endogenous ligand CXCL12.2 In this study, we investigated the interaction and mechanism of intracellular loop 1 pepducins with CXCR4.

Method: Experiments were performed in HEK293 cells stably expressing human CXCR4 tagged with the luciferase, NanoLuc, on its N-terminus (NL-CXCR4) or C-terminus (CXCR4-NL). The binding and displacement of fluorescently labelled CXCR4 ligands was studied in a NanoBRET assay3 at equilibrium or as kinetic experiments reading once every minute using NL-CXCR4 or CXCR4-NL cells or membranes quantified on a PHERAstar FS plate reader (BMG).

Results: The affinity of fluorescent CXCL12 (CXCL12-red) was determined in NL-CXCR4 cells and membranes using NanoBRET saturation binding (pKd(Cells)=7.15±0.04, n=5; pKd(Membranes)=7.61±0.10, n=5) or alternatively the association binding kinetics in cells using 1.5625 to 100nM (pKd=7.10±0.18, n=7) were analysed. Competition binding experiments in membranes showed that CXCL12-red binding was inhibited by pre-incubation with small molecules AMD3100 (pKi=7.03±0.04, n=5), IT1t (pKi=8.07±0.02, n=5) and CXCR4 pepducin ATI-2341 (pKi<6, maximal inhibition 58.3±2.2% (10μM), n=5). Control pepducins missing a lipid tail or the last three amino acids did not displace CXCL12-red at concentrations up to 10 μM. Displacement of CXCL12-red by ATI-2341 was followed in a kinetic assay in cells. ATI-2341 (10μM) shows displacement of CXCL12-red which reaches a plateau of 53.47±0.98% of the initial signal within 10 minutes (koff=0.43±0.04 min-1, n=5). ATI-2341f, a TAMRA-labelled ATI-2341, was used in the membrane binding assay to detect interaction with the Nluc-CXCR4 receptor. ATI-2431f showed no displaceable binding towards the N-terminal labelled NL-CXCR4, but did interact with the C-terminal CXCR4-NL. In CXCR4-NL cells, binding of ATI-2341f reached saturation after 15 min and displacement with high concentrations of ATI-2341 was possible within 10 minutes. AMD3100, IT1t and CXCL12 are not able to displace ATI-2341f binding at concentrations up to 100 or 1 μM, respectively.

Conclusion: These data suggest that ATI-2341 interacts with CXCR4 from an allosteric site on the inner leaflet of the cell membrane. Moreover, ATI-2341 decreases the binding of CXCL12 to CXCR4 suggesting an influence on the orthosteric binding site.

Refrences:

1. Covic et al.(2002). PNAS 99:643-648.

2. Tchernychev et al.(2010). PNAS 107:22255-22259.

3. Stoddart et al.(2015). Nature Methods 12:661-663.